| 1 |
33812801 | Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer. | 2021 Jun |
1 |
| 2 |
32432260 | The leaving group in Au(I)-phosphine compounds dictates cytotoxic pathways in CEM leukemia cells and reactivity towards a Cys2His2 model zinc finger. | 2020 Nov 25 |
1 |
| 3 |
30895171 | Targeting Oxidative Stress With Auranofin or Prima-1Met to Circumvent p53 or Bax/Bak Deficiency in Myeloma Cells. | 2019 |
1 |
| 4 |
30940656 | Auranofin Protects Intestine against Radiation Injury by Modulating p53/p21 Pathway and Radiosensitizes Human Colon Tumor. | 2019 Aug 1 |
2 |
| 5 |
31780660 | Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma. | 2019 Nov 28 |
1 |
| 6 |
25096914 | Auranofin displays anticancer activity against ovarian cancer cells through FOXO3 activation independent of p53. | 2014 Oct |
2 |
| 7 |
19838062 | p53-dependent inhibition of TrxR1 contributes to the tumor-specific induction of apoptosis by RITA. | 2009 Nov 1 |
1 |